Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.2927
-0.0564 (-16.16%)
At close: Jun 27, 2025, 4:00 PM
0.3125
+0.0198 (6.76%)
After-hours: Jun 27, 2025, 7:09 PM EDT
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$2,369,248
Market Cap
50.38M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
RENB News
- 25 days ago - Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform - GlobeNewsWire
- 5 weeks ago - UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - GlobeNewsWire
- 5 weeks ago - Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - GlobeNewsWire
- 6 weeks ago - Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform - GlobeNewsWire
- 6 weeks ago - Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics - GlobeNewsWire
- 2 months ago - Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs - GlobeNewsWire
- 2 months ago - Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewsWire
- 3 months ago - Renovaro Provides Update to Definitive Agreement with Predictive Oncology - GlobeNewsWire